FI852804L - Farmaceutiska preparat med reglerbar utloesning. - Google Patents

Farmaceutiska preparat med reglerbar utloesning.

Info

Publication number
FI852804L
FI852804L FI852804A FI852804A FI852804L FI 852804 L FI852804 L FI 852804L FI 852804 A FI852804 A FI 852804A FI 852804 A FI852804 A FI 852804A FI 852804 L FI852804 L FI 852804L
Authority
FI
Finland
Prior art keywords
registration
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
FI852804A
Other languages
English (en)
Finnish (fi)
Other versions
FI852804A0 (fi
FI852804A7 (fi
Inventor
Yegnaswami Raghunathan
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of FI852804A0 publication Critical patent/FI852804A0/fi
Publication of FI852804A7 publication Critical patent/FI852804A7/fi
Publication of FI852804L publication Critical patent/FI852804L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI852804A 1984-07-18 1985-07-17 Farmaceutiska preparat med reglerbar utloesning. FI852804L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63197984A 1984-07-18 1984-07-18

Publications (3)

Publication Number Publication Date
FI852804A0 FI852804A0 (fi) 1985-07-17
FI852804A7 FI852804A7 (fi) 1986-01-19
FI852804L true FI852804L (fi) 1986-01-19

Family

ID=24533574

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852804A FI852804L (fi) 1984-07-18 1985-07-17 Farmaceutiska preparat med reglerbar utloesning.

Country Status (11)

Country Link
EP (1) EP0171528A3 (fr)
JP (1) JPH0649645B2 (fr)
KR (1) KR920007568B1 (fr)
AU (1) AU571659B2 (fr)
CA (1) CA1236023A (fr)
DK (1) DK324385A (fr)
FI (1) FI852804L (fr)
NO (1) NO852880L (fr)
NZ (1) NZ211449A (fr)
PH (1) PH20391A (fr)
ZA (1) ZA853462B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0248051A1 (fr) * 1985-11-29 1987-12-09 FISONS plc Composition pharmaceutique comprenant du cromoglycate de sodium
IE62100B1 (en) * 1986-07-30 1994-12-14 Fisons Corp Coated ion exchange resins
NZ219925A (en) * 1986-07-30 1989-06-28 Pennwalt Corp Polymer-treated sulphonic acid cationic exchange resin particles
US4859461A (en) * 1986-07-30 1989-08-22 Fisons Corporation Coatable ion exchange resins
US4859462A (en) * 1986-07-30 1989-08-22 Fisons Corporation Polymer-treated ion exchange resins
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
US4999189A (en) * 1988-11-14 1991-03-12 Schering Corporation Sustained release oral suspensions
US5186930A (en) * 1988-11-14 1993-02-16 Schering Corporation Sustained release oral suspensions
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof
IT1241417B (it) 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
JP3286315B2 (ja) * 1990-06-20 2002-05-27 アドバンスト ポリマー システムズ，インコーポレイティド 可溶性活性物質の調節された放出のための組成物及び方法
CZ119793A3 (en) * 1990-12-21 1994-01-19 Richardson Vicks Inc Pharmaceutical preparation
JP3278192B2 (ja) * 1992-04-03 2002-04-30 ロート製薬株式会社 徐放性液剤
US5350584A (en) * 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
JP4808405B2 (ja) 2002-11-26 2011-11-02 ホ−レンベック ギャリ− ア−ル 高度に水溶性の電解質薬剤のための水性徐放性ドラッグデリバリーシステム
EP2361611A3 (fr) * 2005-06-09 2011-10-12 Upm Pharmaceuticals, Inc. Système d'administration de médicament à libération prolongée aqueuse pour médicaments électrolytiques fortement solubles dans l'eau
WO2010115015A1 (fr) * 2009-04-03 2010-10-07 Coating Place, Inc. Composition médicamenteuse pharmaceutique à libération modifiée
ES2470940B1 (es) * 2012-12-21 2015-04-16 Laboratorios Rubió, S.A. Aducto entre un poliol y una resina de intercambio iónico
ES2471340B1 (es) 2012-12-21 2015-08-17 Laboratorios Rubió, S.A. Composición farmacéutica oral para fármacos de elevada posología

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
DE2246037B2 (de) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform
FI65910C (fi) * 1976-11-26 1984-08-10 Pennwalt Corp Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations

Also Published As

Publication number Publication date
NO852880L (no) 1986-01-20
DK324385D0 (da) 1985-07-17
EP0171528A3 (fr) 1986-04-23
JPS6130514A (ja) 1986-02-12
FI852804A0 (fi) 1985-07-17
AU3963585A (en) 1986-01-23
EP0171528A2 (fr) 1986-02-19
ZA853462B (en) 1985-12-24
CA1236023A (fr) 1988-05-03
AU571659B2 (en) 1988-04-21
KR860000865A (ko) 1986-02-20
JPH0649645B2 (ja) 1994-06-29
DK324385A (da) 1986-01-19
KR920007568B1 (ko) 1992-09-07
PH20391A (en) 1986-12-10
NZ211449A (en) 1987-08-31
FI852804A7 (fi) 1986-01-19

Similar Documents

Publication Publication Date Title
FI853296A7 (fi) Lääkerae-valmiste.
FI852804A0 (fi) Farmaceutiska preparat med reglerbar utloesning.
FI860559A0 (fi) 11 -fenyl-gonaner, deras framstaellning och dessa innehaollande farmaceutiska preparat.
FI863362L (fi) Farmaceutisk sammansaettning.
FI844199A7 (fi) Lääkeainevalmiste.
FI862094L (fi) Bornerande terapeutisk komposition.
FI872652L (fi) Farmaceutiska preparat med foerdroejd frigivning.
NO861469L (no) Preparat for motvirkning av daarlig aande.
DE3580304D1 (de) Arzneimittel.
FI873630A7 (fi) Stabilt farmaceutiskt preparat.
FI854573A0 (fi) Farmaceutiska kapslar med foerdroejd frigoering.
FI863976L (fi) Terapeutisk komposition.
NO860725L (no) Deres fremstilling.
DE3669105D1 (de) Therapeutische zusammensetzung.
FI865101A0 (fi) Anordning foer registrering av beroering.
FI872313A0 (fi) Farmaceutiska kompositioner.
FI822187A0 (fi) Farmaceutiska preparat
NO864722D0 (no) Tokomponents herdbart preparat.
FI883673A0 (fi) Farmaceutiska kompositioner.
IT1213453B (it) Composizione farmaceutica.
FI874382A0 (fi) Farmaceutiska preparat.
FI852658A0 (fi) Farmaceutiska aemnen.
FI881238A7 (fi) Farmaceutisk beredning.
FI883747A0 (fi) Topiskt anvaendbara farmaceutiska preparat.
AR240319A1 (es) Procedimiento de preparacion de n-sulfamil-3-(2-guanidino-tiazol-4-il-metiltio)-propionamidina.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: PENNWALT CORPORATION